The role of complement in C3 glomerulopathy

PF Zipfel, C Skerka, Q Chen, T Wiech, T Goodship… - Molecular …, 2015 - Elsevier
C3 glomerulopathy describes a spectrum of disorders with glomerular pathology associated
with C3 cleavage product deposition and with defective complement action and regulation …

[HTML][HTML] Novel roles of complement in renal diseases and their therapeutic consequences

T Wada, M Nangaku - Kidney international, 2013 - Elsevier
The complement system functions as a part of the innate immune system. Inappropriate
activation of the complement pathways has a deleterious effect on kidneys. Recent …

[HTML][HTML] C3 glomerulopathy

HT Cook - F1000Research, 2017 - ncbi.nlm.nih.gov
C3 glomerulopathy is a recently defined entity that encompasses a group of kidney diseases
caused by abnormal control of complement activation with deposition of complement …

[HTML][HTML] C3 glomerulopathy: a review with emphasis on ultrastructural features

J Hou, KYM Ren, M Haas - Glomerular Diseases, 2022 - karger.com
Abstract C3 glomerulopathy (C3G) is a rare disease resulting from dysregulation of the
alternative complement pathway, resulting in the deposition of complement component 3 …

Complement C3-targeted therapy in C3 glomerulopathy, a prototype of complement-mediated kidney diseases

MS Meuleman, A Grunenwald, S Chauvet - Seminars in Immunology, 2022 - Elsevier
Abstract C3 glomerulopathy (C3G) is a rare and complex kidney disease that primarily
affects young adults. Renal outcomes remain poor in the absence of specific treatment. C3G …

C3 glomerulopathy: understanding an ultra‐rare complement‐mediated renal disease

AK Heiderscheit, JJ Hauer… - American Journal of …, 2022 - Wiley Online Library
Abstract C3 glomerulopathy (C3G) describes a pathologic pattern of injury diagnosed by
renal biopsy. It is characterized by the dominant deposition of the third component of …

[HTML][HTML] C5 nephritic factors drive the biological phenotype of C3 glomerulopathies

MC Marinozzi, S Chauvet, M Le Quintrec, M Mignotet… - Kidney international, 2017 - Elsevier
C3 Glomerulopathies, which include Dense Deposit Disease and C3 Glomerulonephritis,
are associated with genetic and acquired dysregulation of the C3 convertase alternative …

Complement inhibition in C3 glomerulopathy

CM Nester, RJH Smith - Seminars in immunology, 2016 - Elsevier
Abstract C3 glomerulopathy (C3G) describes a spectrum of glomerular diseases defined by
shared renal biopsy pathology: a predominance of C3 deposition on immunofluorescence …

[HTML][HTML] C4 nephritic factors in C3 glomerulopathy: a case series

Y Zhang, NC Meyer, FC Fervenza, W Lau… - American Journal of …, 2017 - Elsevier
Background C3 glomerulopathy (C3G) defines a group of rare complement-mediated kidney
diseases with a shared underlying pathophysiology: dysregulation of complement in the …

C3 glomerulopathy—understanding a rare complement-driven renal disease

RJH Smith, GB Appel, AM Blom, HT Cook… - Nature reviews …, 2019 - nature.com
The C3 glomerulopathies are a group of rare kidney diseases characterized by complement
dysregulation occurring in the fluid phase and in the glomerular microenvironment, which …